Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Double-Blind Placebo-Controlled Asian Study of Atomoxetine Hydrochloride in the Treatment of Adult Patients with Attention-Deficit/Hyperactivity Disorder (ADHD)
Atomoxetine
B4Z-JE-LYEE
NCT00962104
Attention Deficit Hyperactivity Disorder
Phase 2/Phase 3
 
The annotated case report form is not available. A blank case report form will be provided.
November 2015

Powered by ideaPoint, Inc.